Norway· NO-ID_8B13B9BE-C662-4060-A4D2-B35C5B7447A7
Nasacort
A triamcinolone product containing triamcinolone acetonide, registered in Norway by Opella Healthcare France SAS. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Triamcinolone is registered in 11 of 19 countries.
Countries holding a registration under ATC R01AD11 (triamcinolone), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Triamcinolone · ATC R01AD11
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Triamcinolone Acetonide
- Manufacturer
- Opella Healthcare France SAS
- Country
- Norway (NO)
- ATC code
- R01AD11
- ATC class
- Triamcinolone
- Defined daily dose
- 0.22 mg, N
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
1 priced- no_merkevare_idID_8B13B9BE-C662-4060-A4D2-B35C5B7447A7
- no_varenummer38904030
- no_varenummer090662120NOK 138.1
- gtin7046263890401
- gtin3582910085126
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
38 interactions on record for triamcinolone.
Graded by severity as the source publishes them — 38 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Triamcinolone · interactions on record
38 records
- 38 moderate
Most severe, free to view
- MiconazoleA07AC01moderate
- LonafarnibA16AX20moderate
- VoxelotorB06AX03moderate
- ConivaptanC03XA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Triamcinolone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAllegra Nasal 55 µg/doseSanofi Belgium
- IrelandNASACORT 55 micrograms/dose, nasal spray, suspensionOpella Healthcare France SAS T/A Sanofi
- United States24 Hour Nasal AllergyMeijer Distribution Inc
- GermanyKortikoidRatiopharm Gmbh
- United KingdomAdcortyl in Orabase 0.1% oromucosal pasteBristol-Myers Squibb Pharmaceuticals Ltd
- NetherlandsCremor triamcinolonacetonide 0,1% Mylan, creme 1 mg/gMylan B.V.
- CanadaAPO-TRIAMCINOLONE AQAPOTEX INC
- FinlandAftabMeda Oy
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Volon, Volon A
- Belgium · Delphi, Kenacort-A
- Cyprus · Triacort
- Czechia · Triamcinolon Léčiva
- Germany · Nasacort, Rhinisan
- Denmark · Kenalog, Triamcinolone Acetonide Medipha
- Estonia · Kenalog
- Spain · Nasacort
- Finland · Nasacort, Triamcinolone Medipha
- France · Kenacort Retard, Nasacort
- United Kingdom (Northern Ireland) · Nasacort
- Greece · Jiven, Nasacort
- Croatia · Kenalog
- Hungary · Ftorocort, Kenalog
- Ireland · Nasacort, Nasacort Allergy
- Iceland · Kenacort-T, Nasacort
- Italy · Kenacort, Nasacort
- Lithuania · Ftorocort, Kenalog
- Luxembourg · Delphi, Kenacort-A
- Latvia · Ftorocort, Kenalog
- Malta · Nasacort, Nasacort Allergy
- Netherlands · Cremor Triamcinolonacetonide, Kenacort-A 10
- Poland · Polcortolon
- Portugal · Nasacort, Telfast Spray Nasal
- Sweden · Kenacort-T, Nasacort
- Slovenia · Kenalog
- Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2b31abf-1f43-4b05-815d-6e3de8d0c234 GET /v1/drugs/b2b31abf-1f43-4b05-815d-6e3de8d0c234?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nesespray, suspensjon",
"source": "fest",
"status": "A",
"atc_name": "Triamcinolon",
"merkevare_id": "ID_8B13B9BE-C662-4060-A4D2-B35C5B7447A7",
"name_form_strength": "Nasacort nesespray susp 55 mikrog/dose",
"prescription_group": "CF"
}See everything about triamcinolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.